BAX and cancer: Their therapeutic actions involve decreasing cancer cell viability and altering their morphology and levels of Bcl2 proteins, inflammatory markers, oxidative stress parameters and NF‐kappa whilst increasing Bax/Bcl2 ratio and levels of apoptosis.